MeSH D007024 - orthostatic hypotension
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Droxidopa | Droxidopa | 2021-02-18 | |||
| Mylan | Midodrine | Midodrine | 2003-09-10 | |||
| Xiromed | Ephedrine | Ephedrine | 2022-04-21 | |||
| Midodrine | Midodrine | 2020-10-01 | ||||
| Lupin Research | Droxidopa | Droxidopa | 2021-02-18 | |||
| Sandoz | Ephedrine | Ephedrine | 2017-08-23 | |||
| Takeda | Midodrine | Proamatine | 1996-09-06 |
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
14%6/44
Phase 2
67%4/6
Phase 3
86%6/7
Approved: 4Overall Success rate: 8%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use